These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2377016)

  • 1. [Ocular toxoplasmosis in patients with acquired immunodeficiency syndrome].
    Santín M; Podzamczer D; Bolao F; Prat J; Rufí G; Ariza J; Lillo J
    Med Clin (Barc); 1990 Mar; 94(11):423-5. PubMed ID: 2377016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ocular toxoplasmosis in human immunodeficiency virus infected patients without concurrent central nervous system infection. Report of two cases].
    Ortí A; Roig P; Chipont E; Cuadrado JM; Porras G; Navarro V
    An Med Interna; 1996 Aug; 13(8):390-2. PubMed ID: 8983366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular toxoplasmosis in AIDS patients.
    Gagliuso DJ; Teich SA; Friedman AH; Orellana J
    Trans Am Ophthalmol Soc; 1990; 88():63-86; discussion 86-8. PubMed ID: 2095034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico.
    del Rio-Chiriboga C; Orzechowski-Rallo A; Sanchez-Mejorada G
    Arch Med Res; 1997; 28(4):527-30. PubMed ID: 9428578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence, morphology and therapy of toxoplasmosis chorioretinitis in AIDS].
    Schmitz K; Fabricius EM; Brommer H; Emminger C
    Fortschr Ophthalmol; 1991; 88(6):698-704. PubMed ID: 1794794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular toxoplasmosis and AIDS. A case report].
    Garcher C; Bron A; Bertrand MA; Chirpaz L; Bosc JM
    J Fr Ophtalmol; 1990; 13(1-2):69-73. PubMed ID: 2212511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
    Lebech AM; Lebech M; Børme KK; Mathiesen LR
    Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain lesions in patients with acquired immunodeficiency syndrome.
    Bishburg E; Eng RH; Slim J; Perez G; Johnson E
    Arch Intern Med; 1989 Apr; 149(4):941-3. PubMed ID: 2705847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
    Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
    AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of clindamycin in the treatment of ocular toxoplasmosis].
    Jeddi A; Azaiez A; Bouguila H; Kaoueche M; Malouche S; Daghfous F; Ayed S
    J Fr Ophtalmol; 1997; 20(6):418-22. PubMed ID: 9296037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis.
    Delair E; Monnet D; Grabar S; Dupouy-Camet J; Yera H; Brézin AP
    Am J Ophthalmol; 2008 Dec; 146(6):851-5. PubMed ID: 18723143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxoplasmosis: new aspects, diagnosis and treatment].
    Oksenhendler E; Matheron S
    Rev Prat; 1992 Jan; 42(2):155-9. PubMed ID: 1565998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clindamycin in the treatment of toxoplasmosis in AIDS.
    Iannucci AA; Hart LL
    Ann Pharmacother; 1992 May; 26(5):645-7. PubMed ID: 1591424
    [No Abstract]   [Full Text] [Related]  

  • 16. [Brain lesions in patients with acquired immunodeficiency syndrome].
    Repáraz Padrós J; Regalado de los Cobos J; Uriz Ayestarán J
    Enferm Infecc Microbiol Clin; 1991 Feb; 9(2):85-9. PubMed ID: 1854855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS.
    Grant IH; Gold JW; Rosenblum M; Niedzwiecki D; Armstrong D
    AIDS; 1990 Jun; 4(6):519-21. PubMed ID: 2386617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A spectrum in the pathology of toxoplasmosis in patients with acquired immunodeficiency syndrome.
    Bertoli F; Espino M; Arosemena JR; Fishback JL; Frenkel JK
    Arch Pathol Lab Med; 1995 Mar; 119(3):214-24. PubMed ID: 7887774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment].
    Leport C; Vildé JL; Katlama C; Regnier B; Mathéron S; Saimot AG
    Ann Med Interne (Paris); 1987; 138(1):30-3. PubMed ID: 3592453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.